Luc Tanguay
Nessuna posizione attualmente
Storia della carriera di Luc Tanguay
Precedenti posizioni note di Luc Tanguay
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| THERATECHNOLOGIES INC. | Direttore/Membro del Consiglio | 06/12/1993 | 06/04/2020 |
| Amministratore Delegato | 11/10/2012 | 06/04/2020 | |
| Presidente | 11/10/2012 | 06/04/2020 | |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Direttore/Membro del Consiglio | 22/08/2006 | 31/03/2010 |
Valeo Management LP
 Valeo Management LP Miscellaneous Commercial ServicesCommercial Services Valeo Management LP offers research commercialization services. The firm provides Life sciences and biotechnologies, engineering, information and communications technologies services. The company was founded in 2000 and is headquartered in Montreal, Canada. | Presidente | - | - |
Formazione di Luc Tanguay
| University of Sherbrooke | Graduate Degree |
Statistiche
Distribuzione geografica
| Canada | 5 |
Posizioni
| Director/Board Member | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| THERATECHNOLOGIES INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
Valeo Management LP
Valeo Management LP Miscellaneous Commercial ServicesCommercial Services Valeo Management LP offers research commercialization services. The firm provides Life sciences and biotechnologies, engineering, information and communications technologies services. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
- Borsa valori
- Insiders
- Luc Tanguay
- Esperienza
